These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
432 related articles for article (PubMed ID: 29965778)
21. [Use of sFlt-1/PlGF ratio in preeclampsia : a monocentric retrospective analysis]. Verbeurgt L; Chantraine F; De Marchin J; Minon JM; Nisolle M Rev Med Liege; 2017 Sep; 72(9):393-398. PubMed ID: 28892314 [TBL] [Abstract][Full Text] [Related]
22. First-trimester screening for early and late preeclampsia using maternal characteristics, biomarkers, and estimated placental volume. Sonek J; Krantz D; Carmichael J; Downing C; Jessup K; Haidar Z; Ho S; Hallahan T; Kliman HJ; McKenna D Am J Obstet Gynecol; 2018 Jan; 218(1):126.e1-126.e13. PubMed ID: 29097177 [TBL] [Abstract][Full Text] [Related]
23. Clinical implementation of the sFlt-1/PlGF ratio to identify preeclampsia and fetal growth restriction: A prospective cohort study. Herraiz I; Simón E; Gómez-Arriaga PI; Quezada MS; García-Burguillo A; López-Jiménez EA; Galindo A Pregnancy Hypertens; 2018 Jul; 13():279-285. PubMed ID: 30177066 [TBL] [Abstract][Full Text] [Related]
24. Diagnostic accuracy of the soluble Fms-like tyrosine kinase-1/placental growth factor ratio for preeclampsia: a meta-analysis based on 20 studies. Liu Y; Zhao Y; Yu A; Zhao B; Gao Y; Niu H Arch Gynecol Obstet; 2015 Sep; 292(3):507-18. PubMed ID: 25716670 [TBL] [Abstract][Full Text] [Related]
25. Combination of plasma-soluble fms-like tyrosine kinase 1 and uterine artery Doppler for the prediction of preeclampsia in cases of elderly gravida. Kulmala L; Phupong V Hypertens Res; 2014 Jun; 37(6):538-42. PubMed ID: 24621465 [TBL] [Abstract][Full Text] [Related]
26. Prediction of preeclampsia with angiogenic biomarkers. Results from the prospective Odense Child Cohort. Andersen LB; Dechend R; Jørgensen JS; Luef BM; Nielsen J; Barington T; Christesen HT Hypertens Pregnancy; 2016 Aug; 35(3):405-19. PubMed ID: 27159383 [TBL] [Abstract][Full Text] [Related]
27. Forms of Circulating Luteinizing Hormone Human Chorionic Gonadotropin Receptor for the Prediction of Early and Late Preeclampsia in the First Trimester of Pregnancy. Crovetto F; Figueras F; Crispi F; Triunfo S; Pugia M; Lasalvia L; Chambers AE; Mills WE; Banerjee S; Mercadé I; Casals E; Mira A; Rodriguez-Revenga Bodi L; Gratacós E Fetal Diagn Ther; 2015; 38(2):94-102. PubMed ID: 25676660 [TBL] [Abstract][Full Text] [Related]
28. Circulating angiogenic factors and the risk of preeclampsia. Levine RJ; Maynard SE; Qian C; Lim KH; England LJ; Yu KF; Schisterman EF; Thadhani R; Sachs BP; Epstein FH; Sibai BM; Sukhatme VP; Karumanchi SA N Engl J Med; 2004 Feb; 350(7):672-83. PubMed ID: 14764923 [TBL] [Abstract][Full Text] [Related]
29. Predictive value of angiogenic factors, clinical risk factors and uterine artery Doppler for pre-eclampsia and fetal growth restriction in second and third trimester pregnancies in an Ecuadorian population. Kienast C; Moya W; Rodriguez O; Jijón A; Geipel A J Matern Fetal Neonatal Med; 2016; 29(4):537-43. PubMed ID: 25708492 [TBL] [Abstract][Full Text] [Related]
30. In vivo uteroplacental release of placental growth factor and soluble Fms-like tyrosine kinase-1 in normal and preeclamptic pregnancies. Holme AM; Roland MC; Henriksen T; Michelsen TM Am J Obstet Gynecol; 2016 Dec; 215(6):782.e1-782.e9. PubMed ID: 27503620 [TBL] [Abstract][Full Text] [Related]
31. Uterine artery Doppler and sFlt-1/PlGF ratio: prognostic value in early-onset pre-eclampsia. Gómez-Arriaga PI; Herraiz I; López-Jiménez EA; Escribano D; Denk B; Galindo A Ultrasound Obstet Gynecol; 2014 May; 43(5):525-32. PubMed ID: 24185845 [TBL] [Abstract][Full Text] [Related]
32. sFlt-1, PlGF, sFlt-1/PlGF ratio and uterine artery Doppler for preeclampsia diagnostics. Tarasevičienė V; Grybauskienė R; Mačiulevičienė R Medicina (Kaunas); 2016; 52(6):349-353. PubMed ID: 27940029 [TBL] [Abstract][Full Text] [Related]
33. Analytical evaluation of the novel soluble fms-like tyrosine kinase 1 and placental growth factor assays for the diagnosis of preeclampsia. van Helden J; Weiskirchen R Clin Biochem; 2015 Nov; 48(16-17):1113-9. PubMed ID: 26129879 [TBL] [Abstract][Full Text] [Related]
35. Management of pregnancies after combined screening for pre-eclampsia at 19-24 weeks' gestation. Litwinska M; Syngelaki A; Wright A; Wright D; Nicolaides KH Ultrasound Obstet Gynecol; 2018 Sep; 52(3):365-372. PubMed ID: 29943498 [TBL] [Abstract][Full Text] [Related]
36. Association between adverse pregnancy outcome and imbalance in angiogenic regulators and oxidative stress biomarkers in gestational hypertension and preeclampsia. Turpin CA; Sakyi SA; Owiredu WK; Ephraim RK; Anto EO BMC Pregnancy Childbirth; 2015 Aug; 15():189. PubMed ID: 26303772 [TBL] [Abstract][Full Text] [Related]
37. Prediction of pre-eclampsia combining NGAL and other biochemical markers with Doppler in the first and/or second trimester of pregnancy. A pilot study. Karampas GA; Eleftheriades MI; Panoulis KC; Rizou MD; Haliassos AD; Metallinou DK; Mastorakos GP; Rizos DA Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():153-7. PubMed ID: 27599094 [TBL] [Abstract][Full Text] [Related]
38. Changes in circulating concentrations of soluble fms-like tyrosine kinase-1 and placental growth factor measured by automated electrochemiluminescence immunoassays methods are predictors of preeclampsia. Leaños-Miranda A; Campos-Galicia I; Isordia-Salas I; Rivera-Leaños R; Romero-Arauz JF; Ayala-Méndez JA; Ulloa-Aguirre A J Hypertens; 2012 Nov; 30(11):2173-81. PubMed ID: 22902831 [TBL] [Abstract][Full Text] [Related]
39. First-trimester metabolomic detection of late-onset preeclampsia. Bahado-Singh RO; Akolekar R; Mandal R; Dong E; Xia J; Kruger M; Wishart DS; Nicolaides K Am J Obstet Gynecol; 2013 Jan; 208(1):58.e1-7. PubMed ID: 23159745 [TBL] [Abstract][Full Text] [Related]
40. Combined screening for early and late pre-eclampsia and intrauterine growth restriction by maternal history, uterine artery Doppler, mean arterial pressure and biochemical markers. Litwińska E; Litwińska M; Oszukowski P; Szaflik K; Kaczmarek P Adv Clin Exp Med; 2017; 26(3):439-448. PubMed ID: 28791818 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]